Tonix Pharmaceuticals To Deliver Oral Presentation And Presents Two Posters At The ASCP Annual Meeting May 28-31, 2024
Portfolio Pulse from Benzinga Newsdesk
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) will deliver an oral presentation and present two posters at the ASCP Annual Meeting from May 28-31, 2024. The presentation will focus on Tonmya™ (TNX-102 SL) for fibromyalgia, with NDA preparation in progress. The posters will highlight other TNX-102 SL programs in clinical development, including Long COVID and Acute Stress Disorder.
May 22, 2024 | 12:18 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Tonix Pharmaceuticals will present on Tonmya™ for fibromyalgia and other TNX-102 SL programs at the ASCP Annual Meeting. NDA preparation for Tonmya™ is in progress.
The presentation and posters at a major conference like ASCP can increase visibility and credibility for Tonix Pharmaceuticals. The NDA preparation for Tonmya™ indicates progress towards potential market approval, which is likely to positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100